Vai al contenuto

Interazioni tra farmaci

Exenatide injectable + Insulin glargine-lixisenatide

Gravità: Maggiore

Exenatide injectable and Insulin glargine-lixisenatide: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Both products are GLP-1 receptor agonists (lixisenatide in the fixed-dose combination and exenatide), so combining them duplicates therapy without a proven added benefit. Gastrointestinal adverse effects, and hypoglycemia from the insulin component, may be increased.

Cosa significa questa interazione in parole semplici

Exenatide injectable and Insulin glargine-lixisenatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Livello di evidenza: Moderate

Perché avviene

Duplicate GLP-1 receptor agonist activity producing additive pharmacodynamic effects on insulin secretion, gastric emptying and appetite.

Cosa fare

Avoid using two GLP-1 receptor agonists together; choose a single agent and stop the duplicate. If the combination is unavoidable, monitor blood glucose and GI tolerability closely and reduce insulin as needed.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Exenatide injectable e Insulin glargine-lixisenatide, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Exenatide injectable with Insulin glargine-lixisenatide?

MediHelp rates the interaction as major. Exenatide injectable and Insulin glargine-lixisenatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both products are GLP-1 receptor agonists (lixisenatide in the fixed-dose combination and exenatide), so combining them duplicates therapy without a proven added benefit. Gastrointestinal adverse effects, and hypoglycemia from the insulin component, may be increased.

How serious is the interaction between Exenatide injectable and Insulin glargine-lixisenatide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two GLP-1 receptor agonists together; choose a single agent and stop the duplicate. If the combination is unavoidable, monitor blood glucose and GI tolerability closely and reduce insulin as needed.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi